Six-dog study highlights diagnostic hurdles of M. abscessus: full analysis

A newly published retrospective study in the Journal of Small Animal Practice examines six canine cases of Mycobacterium abscessus infection, putting a sharper clinical frame around an uncommon but consequential diagnosis in dogs. According to the study abstract, the dogs presented with disease ranging from respiratory signs to cutaneous or subcutaneous nodules, and the authors conclude that diagnosis and treatment were challenging, with patterns that resemble human M. abscessus disease. (merckvetmanual.com)

That matters because non-tuberculous mycobacteria remain easy to miss in small animal practice. In both veterinary and human guidance, these infections are described as diagnostically difficult: clinical signs can be nonspecific, routine bacterial cultures may be inadequate, and definitive diagnosis often depends on collecting the right tissue and specifically requesting acid-fast culture and organism identification. The Merck Veterinary Manual also notes that rapidly growing mycobacteria, including organisms in the chelonae-abscessus group, have been linked to chronic cutaneous lesions in dogs and cats. (cdc.gov)

The broader microbiology helps explain the clinical stakes. CDC describes M. abscessus complex as an environmental mycobacterium found in water, soil, and dust, capable of causing skin, soft tissue, and lung infections. It’s also considered especially difficult to treat because of intrinsic antimicrobial resistance, with human treatment often requiring drainage or debridement plus combination antibiotics for six months to a year or longer. While canine management isn’t the same as human care, that resistance profile helps frame why veterinary cases can become prolonged, expensive, and frustrating for clinicians and pet parents alike. (cdc.gov)

Recent veterinary lab data suggest this is not purely a theoretical concern. A 2025 report on mycobacterial isolates from dogs and cats submitted to the University of Tennessee Veterinary Diagnostic Laboratory identified multiple rapidly growing non-tuberculous mycobacterial groups, including four isolates within the M. abscessus group. That doesn’t establish prevalence in the general dog population, but it does suggest referral and diagnostic labs are encountering these organisms often enough to make species identification and susceptibility testing increasingly relevant. (microbiologyresearch.org)

Direct expert reaction to this specific six-dog paper was limited in publicly available sources at the time of writing. Still, the surrounding expert consensus is consistent: non-tuberculous mycobacteria are hard to diagnose, intrinsically resistant to many antibiotics, and usually merit specialist-level microbiology input. CDC’s clinical overview for healthcare professionals explicitly recommends culture from the site of infection and notes that treatment commonly requires specialist consultation, a principle that translates well to referral veterinary medicine when clinicians are dealing with chronic granulomatous disease or nonhealing lesions. (cdc.gov)

Why it matters: For veterinary professionals, the practical takeaway is less about how many dogs were in the series and more about pattern recognition. When a patient has persistent nodules, draining tracts, pyogranulomatous inflammation, or respiratory disease that isn’t behaving like routine bacterial infection, this study supports moving mycobacteriosis higher on the list. That means planning sampling carefully, alerting the lab to the suspicion of mycobacteria, considering PCR or speciation earlier, and preparing pet parents for a potentially long diagnostic and treatment course. In an era of antimicrobial stewardship, it also reinforces the limits of repeated empiric antibiotic changes without organism-level diagnosis. (cdc.gov)

What to watch: The next step is whether follow-up reports can define which canine presentations are most predictive of M. abscessus, what susceptibility patterns look like across veterinary isolates, and which multidrug protocols deliver acceptable outcomes. Given how sparse the canine literature remains, even small case series like this one may shape how referral clinicians approach chronic cutaneous and respiratory infections over the next few years. (microbiologyresearch.org)